STRO Sutro Biopharma, Inc.
$8.87▼ -0.17%
Healthcare
Other
After hours
$8.87▲ +0.00%
Oct 27, 4:00 PM ET
Volume 453.2K
Avg Volume (10D) 415.6K
Key Metrics & Fundamentals
Market Cap
$147.07M
P/E Ratio
–
Div Yield
0.00%
52W Range
7.15 - 43.85
% vs 50 MA
-45.04%
% vs 200 MA
-61.54%
RSI-14
21.6
MACD Histogram
-0.1700
Beta (1Y vs SPY)
1.07
Free Cash Flow
-$38.29M
Gross Rev
$9.84M
Gross Profit
$9.84M
EBITDA
-$26.70M
COGS
–
Operating Exp
$39.53M
Operating Income
-$29.69M
EBIT
-$29.69M
Pretax Income
-$38.53M
Net Income
-$38.53M
EPS (Diluted)
-2.33
Price & Volume History
Loading chart…
Recent News
Sutro Biopharma Announces First Patient Dosed in Phase 1 Trial of STRO-006, a Next-Generation ITGB6-Targeting ADC, in Advanced Solid Tumors
GlobeNewswire · Oct 21, 2026 8:00 AM ET
Sutro Biopharma Announces Participation at the 17th Annual World ADC Conference
GlobeNewswire · Oct 12, 2026 8:00 AM ET
Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development
GlobeNewswire · Sep 29, 2026 8:00 AM ET
STRO Stock Plummets 15% — What Drove The Selloff?
Stocktwits · Aug 12, 2026 4:07 PM ET
Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study
GlobeNewswire · Aug 12, 2026 7:00 AM ET
Upstream Bio, Inc. (UPB) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 11, 2026 8:35 AM ET
Here Are Friday’s Top Wall Street Analyst Research Calls: Baker Hughes, Etsy, HubSpot, Instacart, JetBlue, Roku, SpaceX, Tower Semiconductor, Trade Desk, and More
24/7 Wall St. · Aug 7, 2026 7:51 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See STRO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.